Literature DB >> 27071937

Increased riboflavin production by knockout of 6-phosphofructokinase I and blocking the Entner-Doudoroff pathway in Escherichia coli.

Shuang Liu1, Pei Kang1, Zhenzhen Cui1, Zhiwen Wang1, Tao Chen2,3.   

Abstract

OBJECTIVES: To construct an Escherichia coli strain capable of producing riboflavin with high titer and yield.
RESULTS: A low copy number plasmid pLS01 containing a riboflavin operon under the control of a constitutive promoter was constructed and introduced into Escherichia coli MG1655. Subsequently, the pfkA, edd and ead genes were disrupted, and the resulting strain LS02T produced 667 mg riboflavin/l in MSY medium supplied with 10 g glucose/l in flask cultivation. In a fed-batch process, riboflavin production of the strain reached 10.4 g/l with a yield of 56.8 mg riboflavin/g glucose.
CONCLUSION: To our knowledge, this is the first report of engineered E. coli strains that can produce more than 10 g riboflavin/l in fed-batch cultivation, indicating that E. coli has potential for riboflavin production.

Entities:  

Keywords:  Escherichia coli; Fed-batch fermentation; Metabolic engineering; Riboflavin

Mesh:

Substances:

Year:  2016        PMID: 27071937     DOI: 10.1007/s10529-016-2104-5

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  Optimization of Effective Minerals on Riboflavin Production by Bacillus subtilis subsp. subtilis ATCC 6051 Using Statistical Designs.

Authors:  Marjan Oraei; Seyed Hadi Razavi; Faramarz Khodaiyan
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jan-Mar

Review 2.  Production of riboflavin and related cofactors by biotechnological processes.

Authors:  Shuang Liu; Wenya Hu; Zhiwen Wang; Tao Chen
Journal:  Microb Cell Fact       Date:  2020-02-13       Impact factor: 5.328

Review 3.  Strategies to Increase the Production of Biosynthetic Riboflavin.

Authors:  Guiling Zhao; Fanyi Dong; Xingzhen Lao; Heng Zheng
Journal:  Mol Biotechnol       Date:  2021-06-22       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.